Filing status
- Accounts due
- 31 December 2026
- Last accounts
- 31 December 2024
- Conf. stmt due
- 1 April 2027
- Last conf. stmt
- 18 March 2026
Atai Life Sciences UK Ltd
- Incorporated
- 19 March 2021 (5 years)
- Industry
- Activities of head offices (70100) Other business support service activities n.e.c. (82990)
- Directors
- Christopher Stokes
- Owned by
- Eli Lilly and Company
- Accounts type
- Small
- Region
- Greater London
- Address
- One Fleet PlaceLondonEC4M 7WS
Officers 2 active
Officer details are public data from the Companies House register.
Director · Appointed 11 September 2026
American
Born November 1978
Stokes, Christopher
Director · Appointed 11 September 2026
American
Born February 1979 (47)
Officer history (8 former)
30 September 2026
11 September 2026
Appointed Stokes, Christopher as Director
11 September 2026
Resigned Rao, Srinivas Gandham as Director
11 September 2026
Resigned Kochendoerfer, Gerd Georg as Director
11 September 2026
11 September 2026
Resigned Barrett, Ryan as Director
18 March 2026
Resigned Raven, Hans-Michael as Director
31 December 2024
Appointed Rao, Srinivas Gandham as Director
31 December 2024
Appointed Kochendoerfer, Gerd Georg as Director
31 December 2024
19 April 2024
Appointed Raven, Hans-Michael as Director
9 February 2024
Resigned Richardson, Anna Margaret as Director
15 August 2022
Resigned Weaver, Greg as Director
13 June 2022
Appointed Richardson, Anna Margaret as Director
19 March 2021
Appointed Barrett, Ryan as Director
19 March 2021
19 March 2021
19 March 2021
Appointed Weaver, Greg as Director
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Eli Lilly and Company
Corporate entity · Notified 21 September 2026
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Public Corporation
Reg. no. 183025-143
Former controllers (2)
21 September 2026
Ceased Ataibeckley Inc. — Owns 75–100% of shares
30 December 2025
Ceased Atai Beckley N.V. — Owns 75–100% of shares
Financials
Balance sheet as at 31 December 2024 · small accounts
- Net Assets
- £626,306
- Cash
- £117,712
- Profit
- (£1,191,845)
- Employees
- 20
- Current Ratio
- 2.4x
- Return on Equity
- -190%
Trend
Net Assets
Balance sheet detail
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Current Assets | £1,079,516 | £847,115 | £685,413 | |
| Debtors | £961,804 | £575,755 | ||
| Cash | £117,712 | £271,360 | £130,184 | £435,556 |
| Creditors (< 1 year) | £453,210 | £458,319 | £482,924 | £1,204,448 |
| Net Current Assets | £626,306 | £388,796 | £202,489 | |
| Net Assets | £626,306 | £388,796 | £202,489 | £249,901 |
| Shareholder Funds | £626,306 | £388,796 | £202,489 | £249,901 |
| Turnover | £3,266,092 | |||
| Admin Expenses | £4,902,760 | |||
| Staff Costs | £2,124,345 | £2,115,708 | £2,547,490 | |
| Operating Profit | (£1,636,668) | |||
| Profit Before Tax | (£1,636,668) | |||
| Tax | £266,266 | |||
| Profit for Period | (£1,191,845) | (£1,524,572) | (£1,902,934) | |
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 17 September 2026 | Appointment of a director | |||
| 17 September 2026 | Termination of appointment of a director | |||
| 16 September 2026 | Appointment of a director | |||
| 15 September 2026 | Termination of appointment of a director | |||
| 15 September 2026 | Termination of appointment of a director |
Some other companies at this address
Other companies in this industry
London
Weybridge
Manchester
Fareham
London
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →